Singular Genomics Systems Inc (OMIC)
0.42
+0.02
(+5.00%)
USD |
NASDAQ |
Apr 23, 10:35
Singular Genomics Systems Gross Profit Margin (Quarterly): -42.28% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -42.28% |
| September 30, 2023 | -14.07% |
| June 30, 2023 | -18.22% |
| Date | Value |
|---|---|
| March 31, 2023 | 6.49% |
| December 31, 2022 | -3.14% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-42.28%
Minimum
Dec 2023
6.49%
Maximum
Mar 2023
-14.24%
Average
-14.07%
Median
Sep 2023
Gross Profit Margin (Quarterly) Benchmarks
| Bruker Corp | 50.36% |
| Azenta Inc | 39.86% |
| Harvard Bioscience Inc | 57.99% |
| Bionano Genomics Inc | 22.74% |
| Akoya Biosciences Inc | 62.75% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -43.22% |
| Return on Assets | -32.31% |
| Return on Invested Capital | -41.35% |
| Profit Margin (Quarterly) | -2.15K% |
| Operating Margin (Quarterly) | -2.34K% |
| Return on Net Operating Assets | -97.59% |